MedTrace Logo

Market Research - Acceptability Study for New MCT Fat Products

NCT04309214 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2020-03-16

No results posted yet for this study

Summary

This is a market research, observational study to evaluate the tolerability and acceptability of MCT supplements for young children, young people and adults with intractable epilepsy, GLUT-1 or PDHD from 3 years to adulthood.

Conditions

  • Ketosis
  • Epilepsy
  • Fatty Acid Oxidation Disorder
  • Malabsorption
  • Ketogenic Diet
  • Medium Chain Triglycerides

Interventions

DIETARY_SUPPLEMENT

MCT fats

Subjects will be asked to take 3 new MCT products for 7 days each over a 25 day period

Sponsors & Collaborators

  • Dr. Schär AG / SPA

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
3 Years
Max Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-26
Primary Completion
2019-01-21
Completion
2019-01-21

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04309214 on ClinicalTrials.gov